Highmark Inc., one of the largest Blue Cross Blue Shield plans in country with 5.2 million customers, has decided to stop covering procedures performed with power morcellation.
According to Reuters, beginning Sept. 1, the insurer will stop coverage for laparoscopic power morcellation in its entire coverage area.
The company has decided to stop coverage amidst concerns that the procedure could spread cancerous cells in women who had not been diagnosed with cancer prior to the procedure. In late July, Johnson & Johnson also announced the voluntarily withdrawal of their power morcellators from the market following concerns about the devices.
According to several studies, a power morcellator could spread cancerous cells during routine hysterectomies or the removal of uterine fibroids. Power morcellators are used to cut up uterine growths so that they may be more easily removed through non-invasive means.
Highmark is the first insurer to stop coverage of power morcellation. As information on the risks of using power morcellators continues to be revealed, it is likely that more insurers could halt coverage in the future.
Women who have been diagnosed with uterine cancer after undergoing a power morcellation procedure should seek legal counsel to determine what their legal rights are. To learn more about these devices and the studies linking power morcellation to cancer, visit our power morecallation lawsuit page.
If you believe that you or a loved one were a victim of these dangerous devices, contact our law firm for a free legal consultation.
Call 1 (855) 722-2552 or fill out the Free Case Evaluation form on this page to get started today.